tiprankstipranks
Trending News
More News >
Revvity, Inc. (CH:PKN)
:PKN
Switzerland Market
Advertisement

Revvity (PKN) Stock Forecast & Price Target

Compare
0 Followers
See the Price Targets and Ratings of:

PKN Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
Revvity
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

PKN Stock 12 Month Forecast

There Are No Analyst Ratings for CH:PKN In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

PKN Financial Forecast

PKN Earnings Forecast

Next quarter’s earnings estimate for PKN is $1.25 with a range of $1.16 to $1.28. The previous quarter’s EPS was $0.95. PKN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.09% of the time in the same period. In the last calendar year PKN has Preformed in-line its overall industry.
Next quarter’s earnings estimate for PKN is $1.25 with a range of $1.16 to $1.28. The previous quarter’s EPS was $0.95. PKN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.09% of the time in the same period. In the last calendar year PKN has Preformed in-line its overall industry.

PKN Sales Forecast

Next quarter’s sales forecast for PKN is $614.44M with a range of $603.32M to $619.70M. The previous quarter’s sales results were $565.41M. PKN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.55% of the time in the same period. In the last calendar year PKN has Preformed in-line its overall industry.
Next quarter’s sales forecast for PKN is $614.44M with a range of $603.32M to $619.70M. The previous quarter’s sales results were $565.41M. PKN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.55% of the time in the same period. In the last calendar year PKN has Preformed in-line its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Wells Fargo
CHF81.12
Hold
Reiterated
10/28/25
Wells Fargo Sticks to Their Hold Rating for Revvity (RVTY)
Robert W. Baird
CHF97.03CHF97.82
Buy
Reiterated
10/28/25
Revvity price target raised to $123 from $122 at BairdRevvity price target raised to $123 from $122 at Baird
Raymond James Analyst forecast on CH:PKN
Raymond James
Raymond James
CHF91.46
Buy
Reiterated
10/28/25
Analysts Offer Insights on Healthcare Companies: BioMarin Pharmaceutical (NASDAQ: BMRN) and Revvity (NYSE: RVTY)
TD Cowen
CHF100.21CHF95.43
Buy
Reiterated
10/27/25
Revvity: Buy Rating Affirmed Amid Strong Q3 Performance and Strategic Positioning
Guggenheim Analyst forecast on CH:PKN
Guggenheim
Guggenheim
Hold
Reiterated
10/27/25
Analysts' Opinions Are Mixed on These Healthcare Stocks: HCA Healthcare (NYSE: HCA), Revvity (NYSE: RVTY) and ANI Pharmaceuticals (NASDAQ: ANIP)We reiterate our Neutral rating for RVTY.
Bank of America Securities Analyst forecast on CH:PKN
Bank of America Securities
Bank of America Securities
CHF78.73CHF83.51
Buy
Reiterated
10/27/25
Revvity (RVTY) Receives a Buy from Bank of America Securities
TR | OpenAI - 4o Analyst forecast on CH:PKN
TR | OpenAI - 4o
TR | OpenAI - 4o
CHF78.73CHF86.69
Buy
Upgraded
10/27/25
AI Generated ArticleAI Generated Article
Evercore ISI Analyst forecast on CH:PKN
Evercore ISI
Evercore ISI
CHF84.3
Buy
Reiterated
10/27/25
Revvity price target raised to $108 from $106 at Evercore ISIRevvity price target raised to $108 from $106 at Evercore ISI
Barclays Analyst forecast on CH:PKN
Barclays
Barclays
CHF79.53CHF83.51
Buy
Reiterated
10/27/25
Barclays Remains a Buy on Revvity (RVTY)
J.P. Morgan Analyst forecast on CH:PKN
J.P. Morgan
J.P. Morgan
CHF79.53
Hold
Reiterated
10/09/25
J.P. Morgan Sticks to Its Hold Rating for Revvity (RVTY)
KeyBanc
CHF99.41
Buy
Reiterated
09/16/25
KeyBanc Reaffirms Their Buy Rating on Revvity (RVTY)
Leerink Partners Analyst forecast on CH:PKN
Leerink Partners
Leerink Partners
CHF91.46CHF87.48
Buy
Reiterated
09/16/25
Analysts Offer Insights on Healthcare Companies: Ionis Pharmaceuticals (NASDAQ: IONS), Eli Lilly & Co (NYSE: LLY) and Revvity (NYSE: RVTY)
Bernstein Analyst forecast on CH:PKN
Bernstein
Bernstein
CHF95.43CHF91.46
Hold
Reiterated
07/29/25
Revvity (RVTY) Gets a Hold from Bernstein
Stifel Nicolaus Analyst forecast on CH:PKN
Stifel Nicolaus
Stifel Nicolaus
CHF87.48
Hold
Reiterated
07/29/25
Stifel Nicolaus Remains a Hold on Revvity (RVTY)
Jefferies
CHF84.3CHF79.53
Hold
Reiterated
07/28/25
Jefferies Keeps Their Hold Rating on Revvity (RVTY)
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Wells Fargo
CHF81.12
Hold
Reiterated
10/28/25
Wells Fargo Sticks to Their Hold Rating for Revvity (RVTY)
Robert W. Baird
CHF97.03CHF97.82
Buy
Reiterated
10/28/25
Revvity price target raised to $123 from $122 at BairdRevvity price target raised to $123 from $122 at Baird
Raymond James Analyst forecast on CH:PKN
Raymond James
Raymond James
CHF91.46
Buy
Reiterated
10/28/25
Analysts Offer Insights on Healthcare Companies: BioMarin Pharmaceutical (NASDAQ: BMRN) and Revvity (NYSE: RVTY)
TD Cowen
CHF100.21CHF95.43
Buy
Reiterated
10/27/25
Revvity: Buy Rating Affirmed Amid Strong Q3 Performance and Strategic Positioning
Guggenheim Analyst forecast on CH:PKN
Guggenheim
Guggenheim
Hold
Reiterated
10/27/25
Analysts' Opinions Are Mixed on These Healthcare Stocks: HCA Healthcare (NYSE: HCA), Revvity (NYSE: RVTY) and ANI Pharmaceuticals (NASDAQ: ANIP)We reiterate our Neutral rating for RVTY.
Bank of America Securities Analyst forecast on CH:PKN
Bank of America Securities
Bank of America Securities
CHF78.73CHF83.51
Buy
Reiterated
10/27/25
Revvity (RVTY) Receives a Buy from Bank of America Securities
TR | OpenAI - 4o Analyst forecast on CH:PKN
TR | OpenAI - 4o
TR | OpenAI - 4o
CHF78.73CHF86.69
Buy
Upgraded
10/27/25
AI Generated ArticleAI Generated Article
Evercore ISI Analyst forecast on CH:PKN
Evercore ISI
Evercore ISI
CHF84.3
Buy
Reiterated
10/27/25
Revvity price target raised to $108 from $106 at Evercore ISIRevvity price target raised to $108 from $106 at Evercore ISI
Barclays Analyst forecast on CH:PKN
Barclays
Barclays
CHF79.53CHF83.51
Buy
Reiterated
10/27/25
Barclays Remains a Buy on Revvity (RVTY)
J.P. Morgan Analyst forecast on CH:PKN
J.P. Morgan
J.P. Morgan
CHF79.53
Hold
Reiterated
10/09/25
J.P. Morgan Sticks to Its Hold Rating for Revvity (RVTY)
KeyBanc
CHF99.41
Buy
Reiterated
09/16/25
KeyBanc Reaffirms Their Buy Rating on Revvity (RVTY)
Leerink Partners Analyst forecast on CH:PKN
Leerink Partners
Leerink Partners
CHF91.46CHF87.48
Buy
Reiterated
09/16/25
Analysts Offer Insights on Healthcare Companies: Ionis Pharmaceuticals (NASDAQ: IONS), Eli Lilly & Co (NYSE: LLY) and Revvity (NYSE: RVTY)
Bernstein Analyst forecast on CH:PKN
Bernstein
Bernstein
CHF95.43CHF91.46
Hold
Reiterated
07/29/25
Revvity (RVTY) Gets a Hold from Bernstein
Stifel Nicolaus Analyst forecast on CH:PKN
Stifel Nicolaus
Stifel Nicolaus
CHF87.48
Hold
Reiterated
07/29/25
Stifel Nicolaus Remains a Hold on Revvity (RVTY)
Jefferies
CHF84.3CHF79.53
Hold
Reiterated
07/28/25
Jefferies Keeps Their Hold Rating on Revvity (RVTY)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Revvity

1 Month
xxx
Success Rate
18/34 ratings generated profit
53%
Average Return
+0.38%
reiterated a xxx
rating 10 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 52.94% of your transactions generating a profit, with an average return of +0.38% per trade.
3 Months
xxx
Success Rate
21/34 ratings generated profit
62%
Average Return
+2.19%
reiterated a xxx
rating 10 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 61.76% of your transactions generating a profit, with an average return of +2.19% per trade.
1 Year
Success Rate
19/35 ratings generated profit
56%
Average Return
+6.07%
reiterated a buy rating 10 days ago
Copying Catherine Ramsey Schulte's trades and holding each position for 1 Year would result in 55.88% of your transactions generating a profit, with an average return of +6.07% per trade.
2 Years
xxx
Success Rate
15/34 ratings generated profit
44%
Average Return
+6.61%
reiterated a xxx
rating 10 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 44.12% of your transactions generating a profit, with an average return of +6.61% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

PKN Analyst Recommendation Trends

Rating
Jun 25
Jul 25
Aug 25
Sep 25
Oct 25
Strong Buy
0
0
0
0
0
Buy
20
18
15
15
7
Hold
14
13
15
12
7
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
34
31
30
27
14
In the current month, PKN has received 7 Buy Ratings, 7 Hold Ratings, and 0 Sell Ratings. PKN average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

PKN Stock Forecast FAQ

What is CH:PKN’s average 12-month price target, according to analysts?
Currently, no data Available
What is CH:PKN’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for CH:PKN, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is Revvity, Inc. a Buy, Sell or Hold?
      Currently, no data Available
      What is Revvity, Inc.’s share price target?
      Currently, no data Available
      What do analysts say about Revvity, Inc.?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of Revvity, Inc.?
      To buy shares of CH:PKN, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis